SCHEDULE: FMR LLC Reports 11.6% Stake in ATEA Pharmaceuticals
Beneficial Ownership Update
FMR LLC and Abigail P. Johnson have filed an Amendment No. 8 to Schedule 13G, disclosing a beneficial ownership of 11.6% in ATEA Pharmaceuticals Inc. common stock as of November 28, 2025.
Summary
- FMR LLC and Abigail P. Johnson collectively beneficially own 9,095,679.87 shares of ATEA Pharmaceuticals Inc. common stock.
- This aggregate amount represents 11.6% of the total outstanding common stock of ATEA Pharmaceuticals Inc.
- FMR LLC holds sole voting power over 9,093,717.00 shares and sole dispositive power over 9,095,679.87 shares.
- Abigail P. Johnson, as a control person of FMR LLC, is deemed to have shared dispositive power over 9,095,679.87 shares.
- Fidelity Growth Company Commingled Pool, an entity under FMR LLC, holds 5,456,339.00 shares, representing 7.0% of the total outstanding common stock as of November 28, 2025.
- The filing is an Amendment No. 8 to a previously filed Schedule 13G, indicating an update to an existing beneficial ownership position.
Sentiment
Score: 5
Explanation: The filing is a factual disclosure of beneficial ownership and does not contain information that inherently conveys positive or negative sentiment regarding the issuer's performance or prospects. It merely updates an existing institutional holding.
Future Outlook
NA
Industry Context
This filing reflects a significant institutional investment in ATEA Pharmaceuticals, a common occurrence in the pharmaceutical sector where large asset managers like FMR LLC often hold substantial stakes in publicly traded companies.
Stakeholder Impact
- Shareholders: The disclosure of a significant 11.6% stake by a major institutional investor like FMR LLC can influence investor confidence and perception of the company's stability and attractiveness.
- Market Participants: The reported ownership provides transparency regarding the company's shareholder base, which is crucial for market analysis and trading decisions.
Key Dates
| Date | Description |
|---|---|
| 2023-01-03 | Effective date of Power of Attorney for Stephanie J. Brown on behalf of FMR LLC. |
| 2023-01-26 | Effective date of Power of Attorney for Stephanie J. Brown on behalf of Abigail P. Johnson. |
| 2025-11-28 | Date of event which requires filing of this statement, reflecting the beneficial ownership percentage. |
| 2025-12-04 | Date of signing for the Schedule 13G filing by FMR LLC and Abigail P. Johnson. |
Keywords
ATEA Pharmaceuticals, FMR LLC, Abigail P. Johnson, Beneficial Ownership, Schedule 13G, Institutional Investor, Common Stock, Fidelity
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.